R&D Costs and Returns by Therapeutic Category Joseph A. DiMasiHenry G. GrabowskiJohn Vernon Clinical and Non-Clinical Drug Development 30 December 2004 Pages: 211 - 223
Electronic Patient Diaries in a Clinical Trial—The Holistic Approach Heidi E. SheaCharles PrestonSpencer Hudson Clinical and Non-Clinical Drug Development 30 December 2004 Pages: 225 - 238
From Informed Consent through Database Lock: An Interactive Clinical Trial Conducted Using the Internet Kristin L. EilenbergAmy M. HooverScott Segal Clinical and Non-Clinical Drug Development 30 December 2004 Pages: 239 - 251
Biotechnology Regulation: Views of the Authorities, Investors, and Product Developers in Finland Outi NieminenLeena RahkamoKatrina Nordström Drug Regulation 30 December 2004 Pages: 253 - 264
Valuing the Drug Information Provided for Generics in Setting the Price of Generic Drugs in Japan Hisashi IijimaTeruyo KurosakiMakoto Shiragami Drug Regulation 30 December 2004 Pages: 265 - 272
The Regulation of Herbal Medicinal Products in Armenia Emil GabrielyanElmira AmroyanGagik Grigoryan Drug Regulation 30 December 2004 Pages: 273 - 281
A Statistical Design Consideration in Robotic Systems Stan AltanAreti ManolaDamaraju Raghavarao Statistics 30 December 2004 Pages: 283 - 286
Clinical Trial Design Issues for Chronic Hepatitis B Yeong-Liang Lin Statistics 30 December 2004 Pages: 287 - 291
Practical Considerations in Developing an Automated Signaling Program within a Pharmacovigilance Department Chuen L. YeeSteve L. KlincewiczRick Wilson Drug Safety 30 December 2004 Pages: 293 - 300
Attitudes of Older Americans toward Direct-to-Consumer Advertising: Predictors of Impact Jacqueline S. MarinacLincoln A. GodfreySandra K. Willsie Drug Information 30 December 2004 Pages: 301 - 311